Target
Growth hormone secretagogue receptor type 1
Ligand
BDBM21944
Substrate
BDBM10852
Meas. Tech.
Fluorescence Imaging Plate Reader (FLIPR) Assay
pH
7.2000±n/a
Temperature
295.1500±n/a K
EC50
14.6±n/a nM
Citation
 Li, JChen, SYLi, JJWang, HHernandez, ASTao, SMusial, CMQu, FSwartz, SChao, STFlynn, NMurphy, BJSlusarchyk, DASeethala, RYan, MSleph, PGrover, GSmith, MABeehler, BGiupponi, LDickinson, KEZhang, HHumphreys, WGPatel, BPSchwinden, MStouch, TCheng, PTBiller, SAEwing, WRGordon, DRobl, JATino, JA Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180). J Med Chem 50:5890-3 (2007) [PubMed]  Article 
Target
Name:
Growth hormone secretagogue receptor type 1
Synonyms:
Ghrelin receptor 1a (GHS-R1a) | GH-releasing peptide receptor | Ghrelin Receptor (Growth Hormone Secretagogue Receptor Type 1) | GHS-R | GHRP | GHSR_HUMAN | GHSR | Ghrelin receptor
Type:
Receptor
Mol. Mass.:
41334.57
Organism:
Human
Description:
Receptor binding studies use plasma membranes from LLC PK-1 cells transiently transfected with hGHSR1a.
Residue:
366
Sequence:
MWNATPSEEPGFNLTLADLDWDASPGNDSLGDELLQLFPAPLLAGVTATCVALFVVGIAGNLLTMLVVSRFRELRTTTNLYLSSMAFSDLLIFLCMPLDLVRLWQYRPWNFGDLLCKLFQFVSESCTYATVLTITALSVERYFAICFPLRAKVVVTKGRVKLVIFVIWAVAFCSAGPIFVLVGVEHENGTDPWDTNECRPTEFAVRSGLLTVMVWVSSIFFFLPVFCLTVLYSLIGRKLWRRRRGDAVVGASLRDQNHKQTVKMLAVVVFAFILCWLPFHVGRYLFSKSFEPGSLEIAQISQYCNLVSFVLFYLSAAINPILYNIMSKKYRVAVFRLLGFEPFSQRKLSTLKDESSRAWTESSINT
  
Inhibitor
Name:
BDBM21944
Synonyms:
2-{5-[(1S)-1-(2-amino-2-methylpropanamido)-2-(benzyloxy)ethyl]-1H-1,2,3,4-tetrazol-1-yl}ethyl N-(5-hydroxypentyl)carbamate | Tetrazole-based compound, 10
Type:
Small organic molecule
Emp. Form.:
C22H35N7O5
Mol. Mass.:
477.27
SMILES:
CC(C)(N)C(=O)N[C@H](COCc1ccccc1)c1nnnn1CCOC(=O)NCCCCCO |r|
Structure:
Search PDB for entries with ligand similarity:
Substrate